Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults. Optimization of Clinical Response, Remission, Quality of Life and Analysis of Prognostic Markers
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Population: Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic sclerosis dSS). Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA. These 5 cohorts will be subject to standardized clinical monitoring.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 50
Healthy Volunteers: f
View:
• Diagnosis of juvenile idiopathic arthritis, rheumatoid arthritis and seronegative / psoriatic / undifferentiated arthritis, systemic lupus erythematosus or diffuse systemic sclerosis (ACR criteria).
• Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.
Locations
Other Locations
Belgium
UCLouvain
RECRUITING
Brussels
Contact Information
Primary
Patrick Durez
patrick.durez@uclouvain.be
+32 02 764 53 89
Time Frame
Start Date: 2013-09-11
Estimated Completion Date: 2028-03-31
Participants
Target number of participants: 1000
Treatments
juvenile idiopathic arthritis (JIA)
aged \<= 16 y.o. recent diagnosis of JIA and DMARDs treatment-naive patients; aged \<18 y.o. recent diagnosis of JIA
rheumatoid arthritis (RA)
aged =\>18; =\< 50 y.o. recent diagnosis of RA and DMARDs treatment-naive patients
diffuse systemic sclerosis (dSS)
aged =\>18; =\< 50 y.o. recent diagnosis of dSS and DMARDs treatment-naive patients
seronegative arthritis (UA)
aged =\>18; =\< 50 y.o. recent diagnosis of UA and DMARDs treatment-naive patients
systemic lupus erythematosus (SLE)
aged =\>18; =\< 50 y.o. recent diagnosis of SLE and DMARDs treatment-naive patients
Related Therapeutic Areas
Sponsors
Leads: Université Catholique de Louvain